| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.63 | 0.003 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.42 | 0.03 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.42 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.4 | 0.03 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.39 | 0.06 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.33 | 0.09 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.29 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.28 | 0.2 |